Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Delhi HC Restrains Use of CALDIMUST Trademark Deceptively Similar to Mankinds CALCIMUST

Mankind Pharma to give Rs 11 lakh each to 20 Tokyo Olympics players who missed medals

Ruchika Sharma14 Aug 2021 10:00 AM IST

New Delhi: Drug firm Mankind Pharma said it has decided to felicitate 20 Indian players who narrowly missed medals in the recently held Tokyo...

Unichem Labs gets USFDA nod for Metformin Hydrochloride ER Tablets

Ruchika Sharma13 Aug 2021 12:03 PM IST

Mumbai: Drugmaker, Unichem Laboratories Limited, has recently announced that the company has received Abbreviated New Drug Application (ANDA)...

Work towards increasing share of generic drugs in India: Mandaviya tells Pharma Industry

Ruchika Sharma13 Aug 2021 12:00 PM IST

New Delhi: Union Health Minister Mansukh Mandaviya on Thursday urged the pharma industry to consider domestic manufacturing of medicines which are...

India in discussion to buy 50 million Pfizer COVID vaccine doses: Report

Ruchika Sharma13 Aug 2021 11:00 AM IST

New Delhi: India is in talks to buy 50 million doses of Pfizer Inc and German partner BioNTech SE's COVID-19 vaccine, the Wall Street...

Over 70 million Covaxin doses supplied, more in pipeline: Bharat Biotech

Ruchika Sharma13 Aug 2021 10:00 AM IST

Suchitra Ella said that Covaxin has 65 percent efficacy against Delta variant of Covid-19.

Cipla bags USFDA nod for generic version of Durezol

Ruchika Sharma12 Aug 2021 2:15 PM IST

Mumbai: Drug major, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...

RDIF proposes Pfizer conduct joint trials with Sputnik Light as booster shot

Ruchika Sharma12 Aug 2021 12:00 PM IST

New Delhi: The Russian Direct Investment Fund (RDIF) has proposed that US drugmaker Pfizer start joint trials with Sputnik Light as a booster COVID-19...

NPPA finds new Chairman in IAS Kamlesh Kumar Pant

Ruchika Sharma12 Aug 2021 11:22 AM IST

New Delhi: Senior bureaucrat Kamlesh Kumar Pant has been appointed as chairperson of the National Pharmaceutical Pricing Authority (NPPA) as part of...

iSERA Biological begins COVID drug human trials

Ruchika Sharma12 Aug 2021 11:00 AM IST

The results so far have been encouraging, Pratap Deshmukh said, adding the company will be able to deliver the drug at a tenth of the cost charged by...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Cadila Healthcare net profit up 29 percent to Rs 587 crore in Q1

Ruchika Sharma12 Aug 2021 10:00 AM IST

New Delhi: Drug firm Cadila Healthcare on Wednesday reported a 29.33 per cent rise in its consolidated net profit to Rs 587.2 crore for the quarter...

Study on mixing of Covaxin, Covishield doses get DCGI okay

Ruchika Sharma11 Aug 2021 4:04 PM IST

New Delhi: India's drug regulator has given approval for a study to be conducted by the Christian Medical College (CMC), Vellore on mixing of COVID-19...

Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation

Bayer loses another appeal against Roundup cancer verdict

Ruchika Sharma11 Aug 2021 12:55 PM IST

San Francisco: German pharmaceutical and chemical giant Bayer on Monday lost another appeal against a verdict that found its Roundup weedkiller causes...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok